Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimmune Activation in Austism: Imaging Translocator Protein Using Positron Emission Tomography (PET)

NCT01322555 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT01322555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimmune Activation in Austism: Imaging Translocator Protein Using Positron Emission Tomography (PET)
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Observational
Overall status
Terminated
Start date
March 4, 2011
Completion date
July 14, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorders, brain disease, healthy volunteers